Announcements
TECAN GROUP, LTD. SELECTS CLINIVATION WORLDVIEW.
Leader in the Life Sciences supply industry selects
clinivation WorldView as its most comprehensive, authoritative resource
for building its medical product submissions and registrations worldwide.
Framingham, MA, February 22,
2007 - clinivation, Inc. announced today that Tecan Group,
Ltd. (SWX: TECN) has selected clinivation WorldViewTM
Online Regulatory Intelligence solution.
"We are delighted that Tecan has selected clinivation
WorldView as their source for worldwide regulatory intelligence
and procedures," remarked Richard Morroney, R.A.C., C.Q.A., clinivation's
Vice President of Quality and Regulatory Solutions, "With unlimited access to information on >99% of the world markets, Tecan will be readily alerted of important updates to the submission and approval processes," he continued.
Clinivation WorldView is your most comprehensive,
authoritative, and up-to-date resource for building all of your
medical device submissions and registrations worldwide. Clinivation
WorldView also interoperates with clinivation GlobalTM
enterprise software to make building and tracking medical device
submissions and registrations easier than ever before.
About Tecan Group, Ltd.
Tecan Group, Ltd. is a leading global supplier for
the Bipharma, Diagnostic and Forensics industries, specializing
in the development, production, distribution and servicing of enabling
solutions for the discovery of pharmaceutical substances, as well
as for genomics, proteomics, and diagnostics.
Tecan operates manufacturing, R&D sites in both North America and Europe. A sales and service network is maintained in over 50 countries.
For further information, visit www.tecan.com.
About clinivation, Inc.
Clinivation's business is productivity- taking the time and labor out of making better medical products.
Since 1999, our productivity software and solutions have delivered superior value to market leaders in medical devices, pharmaceuticals, and diagnostics.
Visit clinivation online at www.clinivation.com. For further information, please contact:
|
